Saturday, July 11, 2026

Drug profile · INN

tg103 22.5 mg

tg103 22.5 mg is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tg103 22.5 mg
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

tg103 22.5 mg is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tg103 22.5 mg

Approval history

Authority Status Date
NMPA clinical trials

Frequently asked questions

What is tg103 22.5 mg?

tg103 22.5 mg is an FDA-listed pharmaceutical active ingredient.